Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Cytology is usually the first step in investigating serous effusions, to either detect or exclude an underlying malignancy. This study will try to answer the need for improved diagnostic yield of cytologic examination by cell block technique and immunohistochemical testing of three markers which are EZH2, Claudin-4 and MOC-31.
This is a prospective study that will be conducted at the pathology lab of Assiut University Hospital. The study will include effusion specimens (pleural, peritoneal & pericardial) and the aspirated fluid will be examined for physical characters e.g. color and appearance.
The sample will be divided into 2 equal parts: one for conventional smear preparation, and the other for cell block. A minimum of 2 thin smears will be prepared and stained with Papanicolou stain.
Cell block sections of 4-6 μ thickness will be prepared and stained with the hematoxylin and eosin stain (H&E).
For immunohistochemistry, cell blocks will be used. Expression of claudin 4, EZH2, and MOC-31 will be evaluated in benign and malignant cells by using immunoperoxidase technique.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| cases | cytology positive for malignancy | ||
| controls | cytology negative for malignancy |
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| Diagnostic performance of EZH2 | sensitivity and specificity of EZH2 for diagnosis of malignancy | within 48 hours |
| Diagnostic performance of claudin4 | sensitivity and specificity of claudin-4 for diagnosis of malignancy | within 48 hours |
| Diagnostic performance of MOC-31 | sensitivity and specificity of MOC-31 for diagnosis of malignancy | within 48 hours |
| Measure | Description | Time Frame |
|---|---|---|
| Prevalence of malignancy among cases presenting with effusion | percentage of cases diagnosed with malignancy among all cases presenting with effusion | one year |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
all cases that have serous effusion of undiagnosed underlying aetiology.
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Aliaa EM Mahmoud, MSc | Contact | +201007508736 | aliaa.elhosainy88@yahoo.com |
| Name | Affiliation | Role |
|---|---|---|
| Aliaa EM Mahmoud, MSc | Assiut University | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Assiut University Hospital | Recruiting | Asyut | Egypt |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 30156768 | Background | Sundling KE, Cibas ES. Ancillary studies in pleural, pericardial, and peritoneal effusion cytology. Cancer Cytopathol. 2018 Aug;126 Suppl 8:590-598. doi: 10.1002/cncy.22021. |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D010996 | Pleural Effusion |
| D001201 | Ascites |
| D010490 | Pericardial Effusion |
| ID | Term |
|---|---|
| D010995 | Pleural Diseases |
| D012140 | Respiratory Tract Diseases |
| D010335 | Pathologic Processes |
| D013568 | Pathological Conditions, Signs and Symptoms |
Not provided
Not provided
Not provided
Not provided
Not provided
| D006331 | Heart Diseases |
| D002318 | Cardiovascular Diseases |